Antibiotic Treatment for Pediatric Mastitis
For pediatric mastitis, initiate empirical antibiotic therapy targeting Staphylococcus aureus with either oral flucloxacillin/dicloxacillin or cephalexin for outpatient cases, or intravenous nafcillin/oxacillin/cefazolin for hospitalized children, with treatment duration of 10-14 days.
Pathogen and Clinical Context
Staphylococcus aureus is the predominant pathogen in pediatric mastitis, isolated in the majority of culture-positive cases 1, 2. Both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains occur, though MSSA remains more common in neonatal populations 3, 1. The condition typically presents as localized soft tissue infection with erythema, induration, and tenderness around the breast bud, with or without systemic symptoms 4.
Antibiotic Selection Algorithm
For Outpatient Management (Well-Appearing Child with Localized Infection):
First-line oral options:
- Flucloxacillin (beta-lactamase resistant penicillin) - most commonly used with good outcomes 1
- Cephalexin (first-generation cephalosporin) - alternative beta-lactam option
- Clindamycin 10-13 mg/kg/dose every 6-8 hours - if MRSA suspected or beta-lactam allergy 5
The IDSA guidelines for skin and soft tissue infections support using anti-staphylococcal agents as empirical therapy 5. For neonates and young infants, beta-lactamase-resistant antibiotics are reasonable empirical treatment pending culture results 2.
For Hospitalized Children or Complicated Cases:
Intravenous options:
- Nafcillin 50 mg/kg/dose every 6 hours IV 6
- Oxacillin 50 mg/kg/dose every 6 hours IV 6
- Cefazolin 33 mg/kg/dose every 8 hours IV 6
- Vancomycin 15 mg/kg/dose every 6 hours IV - if MRSA suspected or confirmed 5
Hospitalization is indicated for: systemic toxicity, failure of outpatient therapy, inability to tolerate oral medications, or concern for deeper infection 5, 7.
Treatment Duration
10-14 days of antibiotic therapy is recommended 5, 1. The median duration in clinical series was 10 days 1. Treatment should continue until complete resolution of erythema and induration, not just symptomatic improvement.
Critical Management Considerations
Abscess Formation
Approximately 50% of pediatric mastitis cases progress to abscess formation 1. When fluctuance is present, drainage is required in addition to antibiotics 3, 2. Needle aspiration may be attempted for smaller collections, but surgical incision and drainage is often necessary 3, 1. Importantly, two cases with MRSA had good outcomes with surgical drainage despite treatment with beta-lactams, emphasizing that adequate drainage is paramount 1.
Role of Cultures
Breast milk or nipple swab cultures are underutilized (approximately 1% of encounters) 8, but should be obtained when:
- Abscess drainage is performed 3, 1
- Initial antibiotic therapy fails
- MRSA is suspected based on local epidemiology
Gram stain, when available and informative, should guide initial antibiotic selection 2.
MRSA Coverage Considerations
Empirical MRSA coverage is warranted when:
- Local MRSA prevalence is high
- Patient has failed initial beta-lactam therapy
- Systemic toxicity is present
- Previous MRSA infection or colonization
For empirical MRSA coverage in outpatients, clindamycin is preferred in pediatrics (if local resistance <10%) 5. TMP-SMX and tetracyclines are alternatives, though tetracyclines should not be used in children <8 years of age 5.
Common Pitfalls to Avoid
Inadequate drainage of abscesses: Antibiotics alone will not resolve established abscesses; thick fluid collections require drainage 9
Premature discontinuation of antibiotics: Complete the full 10-14 day course even if symptoms improve earlier
Missing MRSA: If clinical response is poor after 48-72 hours on beta-lactam therapy, consider MRSA and broaden coverage 5
Over-investigation in well-appearing neonates: Full sepsis workup including lumbar puncture is not routinely indicated for localized mastitis without systemic signs 4, 7
Failure to support continued breastfeeding: In lactational cases (older children/adolescents), continued milk expression is important 8
Transition to Oral Therapy
For hospitalized patients started on IV antibiotics, transition to oral therapy is appropriate once:
- Clinical improvement is evident (decreased erythema, induration, tenderness)
- Patient is afebrile for 24 hours
- Able to tolerate oral medications
- No evidence of bacteremia or systemic spread
Complete the remainder of the 10-14 day course with oral antibiotics targeting the same pathogen 5.